BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/11/2024 6:17:31 AM | Browse: 191 | Download: 495
 |
Received |
|
2023-09-19 08:09 |
|
Peer-Review Started |
|
2023-09-19 08:10 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-10-09 13:54 |
|
Revised |
|
2023-10-20 06:54 |
|
Second Decision |
|
2023-11-27 02:45 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-12-04 03:24 |
|
Articles in Press |
|
2023-12-04 03:24 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-01-04 02:32 |
|
Publish the Manuscript Online |
|
2024-01-11 06:17 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Application of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in curative surgery for esophageal cancer: A meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Mao-Xiu Yuan, Qi-Gui Cai, Zhen-Yang Zhang, Jian-Zhong Zhou, Cai-Yun Lan and Jiang-Bo Lin |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jiang-Bo Lin, MD, Chief Physician, Department of Thoracic Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou 350000, Fujian Province, China. 18779654883@163.com |
| Key Words |
Esophageal cancer; Neoadjuvant chemoradiotherapy; Radical resection for esophageal cancer; Neoadjuvant chemotherapy; Meta-analysis |
| Core Tip |
Neoadjuvant chemoradiotherapy (nCRT) significantly improves the overall survival rate, pathological complete response rate, and R0 clearance rate for esophageal cancer. However, neoadjuvant chemotherapy (nCT) offers advantages in reducing postoperative cardiopulmonary complications and perioperative mortality. Esophageal squamous cell carcinoma patients benefit more from nCRT in terms of survival rates. The choice between nCRT and nCT should consider the patient's individual conditions and sensitivity to radiotherapy and chemotherapy. Careful consideration is necessary to achieve optimal long-term survival outcomes while minimizing complications. |
| Publish Date |
2024-01-11 06:17 |
| Citation |
Yuan MX, Cai QG, Zhang ZY, Zhou JZ, Lan CY, Lin JB. Application of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in curative surgery for esophageal cancer: A meta-analysis. World J Gastrointest Oncol 2024; 16(1): 214-233 |
| URL |
https://www.wjgnet.com/1948-5204/full/v16/i1/214.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v16.i1.214 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
